Literature DB >> 26397324

Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review.

Masahiro Horikawa1, Shiro Miyayama2, Toshiyuki Irie3, Tatsumi Kaji4, Yasuaki Arai5.   

Abstract

OBJECTIVE: This article reviews the development of transarterial chemoembolization (TACE) in Japan, particularly ethiodized oil-based conventional TACE, from historical, strategic, and technical points of view. We also present the current status of standardized conventional TACE.
CONCLUSION: Conventional TACE has been developed toward a more-selective and hemodynamic-conscious method, along with technical innovation and knowledge accumulation. Standardization of this method is necessary for further scientific evaluation.

Entities:  

Keywords:  Japanese; conventional transarterial chemoembolization; drug-eluting beads; hepatocellular carcinoma; transarterial chemoembolization

Mesh:

Substances:

Year:  2015        PMID: 26397324     DOI: 10.2214/AJR.15.14825

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.

Authors:  Bin Liang; Dan Zhao; Yiming Liu; Xiaopeng Guo; Hongsen Zhang; Lijie Zhang; Chuansheng Zheng
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 2.  The evolution of interventional oncology in the 21st century.

Authors:  Thomas Helmberger
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.039

Review 3.  Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma.

Authors:  Yung-Yeh Su; Yi-Sheng Liu; Chin-Fu Hsiao; Chiun Hsu; Li-Tzong Chen
Journal:  J Hepatocell Carcinoma       Date:  2022-06-02

4.  Incorporation of biochemical factors for survival analysis of transarterial chemoembolization in patients with hepatocellular carcinoma: A retrospective cohort study.

Authors:  Wen-Hui Chan; Song-Fong Huang; Chao-Wei Lee; Tsung-Han Wu; Kuan-Tse Pan; Shi-Ming Lin; Ming-Chin Yu; Chien-Fu Hung
Journal:  J Int Med Res       Date:  2019-08-26       Impact factor: 1.671

5.  Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study.

Authors:  Bin Liang; Hua Xiang; Cong Ma; Bin Xiong; Yilong Ma; Chang Zhao; Yuanhui Yao; Zishu Zhang; Changyong Chen; Haiping Li; Qingyun Long; Jun Zhou; Chao Luo; Huaiming Qiu; Hongyao Hu; Hui Zhao; Guofeng Zhou; Chuansheng Zheng
Journal:  Cancer Manag Res       Date:  2020-02-10       Impact factor: 3.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.